Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E J Reinders

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Transplantation Reviews (Orlando, Fla.)|September 29, 2015
Transplanting the elderly: Balancing aging with histocompatibilityG J Dreyer, A C Hemke, M E J Reinders, et al.
Journal of Immunology Research|August 11, 2015
Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant RecipientsJ R Bank, T J Rabelink, J W de Fijter, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 1, 2011
Donor brain death predisposes human kidney grafts to a proinflammatory reaction after transplantationD K de Vries, J H N Lindeman, J Ringers, et al.
The Journal of Infection|March 3, 2024
Mycophenolate mofetil hampers antibody responses to a broad range of vaccinations in kidney transplant recipients: Results from a randomized controlled studyZ Al Fatly, M G H Betjes, W A Dik, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 6, 2024
The SElf-Care After REnal Transplantation Study: A Retrospective Evaluation of a Home-Monitoring Program Implemented as Standard CareB Hezer, M E J Reinders, M W F van den Hoogen, et al.
Drug Discovery Today|November 28, 2025
Academic-industry collaboration in biomedical innovation: A multi-model review of barriers and facilitatorsJ C J Loggers, M E J Reinders, T van Gelder, et al.
Lupus|December 22, 2012
Concentration-controlled treatment of lupus nephritis with mycophenolate mofetilG M N Daleboudt, M E J Reinders, J den Hartigh, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 5, 2022
Bio-distribution and longevity of mesenchymal stromal cell derived membrane particlesJ Vos, H Tejeda-Mora, A Merino, et al.
British Journal of Clinical Pharmacology|March 26, 2018
A pharmacological rationale for improved everolimus dosing in oncology and transplant patientsR Ter Heine, N P van Erp, H J Guchelaar, et al.
Frontiers in Immunology|January 27, 2023
The detrimental effect of donor-specific antibodies is irrespective of its level in highly-immunized living donor kidney transplant recipients: A case-control seriesT Tramper, D L Roelen, S H Brand-Schaaf, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Transplantation Reviews (Orlando, Fla.)|September 29, 2015
Transplanting the elderly: Balancing aging with histocompatibilityG J Dreyer, A C Hemke, M E J Reinders, et al.
Journal of Immunology Research|August 11, 2015
Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant RecipientsJ R Bank, T J Rabelink, J W de Fijter, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 1, 2011
Donor brain death predisposes human kidney grafts to a proinflammatory reaction after transplantationD K de Vries, J H N Lindeman, J Ringers, et al.
The Journal of Infection|March 3, 2024
Mycophenolate mofetil hampers antibody responses to a broad range of vaccinations in kidney transplant recipients: Results from a randomized controlled studyZ Al Fatly, M G H Betjes, W A Dik, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 6, 2024
The SElf-Care After REnal Transplantation Study: A Retrospective Evaluation of a Home-Monitoring Program Implemented as Standard CareB Hezer, M E J Reinders, M W F van den Hoogen, et al.
Drug Discovery Today|November 28, 2025
Academic-industry collaboration in biomedical innovation: A multi-model review of barriers and facilitatorsJ C J Loggers, M E J Reinders, T van Gelder, et al.
Lupus|December 22, 2012
Concentration-controlled treatment of lupus nephritis with mycophenolate mofetilG M N Daleboudt, M E J Reinders, J den Hartigh, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 5, 2022
Bio-distribution and longevity of mesenchymal stromal cell derived membrane particlesJ Vos, H Tejeda-Mora, A Merino, et al.
British Journal of Clinical Pharmacology|March 26, 2018
A pharmacological rationale for improved everolimus dosing in oncology and transplant patientsR Ter Heine, N P van Erp, H J Guchelaar, et al.
Frontiers in Immunology|January 27, 2023
The detrimental effect of donor-specific antibodies is irrespective of its level in highly-immunized living donor kidney transplant recipients: A case-control seriesT Tramper, D L Roelen, S H Brand-Schaaf, et al.
Pageof 2